US 8748612
Modulators of cystic fibrosis transmembrane conductance regulator
granted A61KA61K31/4375A61P
Quick answer
US patent 8748612 (Modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/4375, A61P, A61P11/00, A61P13/12